ISC takes over travel insurance marketplace TravelInsurance.com
Integrated Specialty Coverages (ISC), a multi-line programme administrator, has acquired US-based independent travel insurance marketplace TravelInsurance.com.
Financial terms of the deal remain undisclosed.
The acquisition is said to enhance ISC's specialty insurance programme portfolio.
TravelInsurance.com enables consumers to compare and purchase travel insurance online.
The platform features products from carriers such as Generali, AXA and Travel Guard, and boasts more than 130,000 verified third-party reviews.
TravelInsurance.com co-founder Drew Sharma said: 'We built TravelInsurance.com to simplify a complex product, making travel insurance transparent and easy to compare and buy online.
'From day one, our focus was to deliver a seamless experience for travellers. ISC shares that same commitment to simplifying insurance, and with its unmatched strength in technology, analytics, operations, and a top-tier management team, we see an incredible opportunity to accelerate our growth and continue setting the standard in the travel insurance market.'
TravelInsurance.com will retain its brand as well as maintain its direct-to-consumer model and relationships with carriers.
The company's founders will remain at the helm and drive its growth as part of the ISC team.
ISC will use its technology and resources to expand TravelInsurance.com's presence and strengthen its position as a travel insurance platform.
The integration of TravelInsurance.com's marketplace with ISC's technology infrastructure and data capabilities is expected to deliver enhanced value to consumers.
ISC CEO Matt Grossberg said: 'TravelInsurance.com brings a best-in-class platform, deep industry relationships and a loyal customer base to ISC.
'Their tech-forward approach and commitment to customer experience perfectly complements our vision of making specialty insurance easy and accessible to consumers. We are thrilled to welcome co-founders Stan Sandberg and Drew Sharma and the entire TravelInsurance.com team to ISC.'
Vista Point Advisors was the exclusive financial advisor to TravelInsurance.com for this transaction.
"ISC takes over travel insurance marketplace TravelInsurance.com" was originally created and published by Life Insurance International, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
30 minutes ago
- Business Wire
SINOVAC Board of Directors Alerts Shareholders to Advantech/Prime Success' New Lawsuit, Which Threatens to Prevent Payment of US$55.00 Special Dividend to All Valid Shareholders
BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (' SINOVAC ' or the ' Company '), a leading provider of biopharmaceutical products in China, today disclosed that on June 12, 2025, Advantech/Prime Success filed a Petition for Emergency Injunctive Relief against SINOVAC, et al., naming as relief parties Cede & Co., The Depository Trust Company, and Equiniti (the dividend paying agent retained by the SINOVAC Board), which may prevent the SINOVAC Board from paying the US$55.00 special dividend as scheduled on or about July 9, 2025. We learned that Vivo Capital's counsel informed the paying agent that Vivo would challenge the dividend and asked the paying agent to withdraw from facilitating the distribution of the US$55.00 dividend declared by the SINOVAC Board to all valid shareholders. The SINOVAC Board has an obligation to answer this Petition on behalf of all SINOVAC common shareholders to stand up to the egregious actions of Prime Success. We expect to file our Opposition Brief today at 5:00 p.m. Atlantic Standard Time, followed by a hearing on Wednesday, June 18. We continue to be shocked by the self-serving, unnecessary actions by Advantech and Vivo Capital (together known as the 'Dissenting Investor Group') against SINOVAC, threatening the rightful dividend payment to all valid SINOVAC common shareholders. These incomprehensible actions are unacceptable to the SINOVAC Board because: The Dissenting Investor Group has already pocketed more than US$1.1 billion in dividends from SINOVAC's operating subsidiary, while all SINOVAC's valid shareholders received nothing. An amount equal to the aggregate amount of cash that would be payable under the US$55.00 per common share special dividend in respect of the 2018 PIPE shares has been set aside by the SINOVAC Board in an escrow account managed by an independent third party pending final resolution of the legal proceedings, which the Dissenting Investor Group initiated. Thus, there is no risk whatsoever that the Dissenting Investor Group's allocations of the dividend will not be paid if the courts ultimately decide in their favor regarding the PIPE shares. These new actions by the Dissenting Investor Group go against their assertions of their support of the US$55.00 dividend payment in their letters to shareholders and raises the question – how can you trust anything they say in their letters or press releases? The SINOVAC Board will continue to fight these frivolous lawsuits, all of which aim to accomplish one thing: to allow the Dissenting Investor group to double dip on dividends. We feel certain we will prevail quickly in this and other proceedings. The SINOVAC Board is on a mission to restore fairness and deliver value to ALL SINOVAC shareholders. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc. The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalification requirements in 2017. The EV71 vaccine, Inlive®, is an innovative vaccine under "Category 1 Preventative Biological Products" and commercialized in China in 2016. In 2022, SINOVAC's Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO. SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine, Panflu®, to the Chinese government stockpiling program. SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities. SINOVAC plans to conduct more extensive and in-depth trade and cooperation with additional countries, and business and industry organizations. Safe Harbor Statement This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as 'may,' 'will,' 'expect,' 'anticipate,' 'aim,' 'estimate,' 'intend,' 'plan,' 'believe,' 'potential,' 'continue,' 'is/are likely to' or other similar expressions. Such statements are based upon current expectations and relate to events that involve known or unknown risks, uncertainties and other factors, including without limitation risks, uncertainties and factors related to the timing of filings, hearings and other litigation-related matters, all of which are difficult to predict and many of which are beyond the Company's control, which may cause actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.
Business Journals
an hour ago
- Business Journals
Luxury and lifestyle hospitality: Why investors are checking in
In a climate defined by volatility across commercial real estate, the hospitality sector, especially in luxury, upper-upscale and lifestyle segments, is emerging as a resilient and strategic investment choice. Miami-based Driftwood Capital, with its vertically integrated model and dedicated Driftwood Lifestyle & Luxury (DLLX) division, is uniquely positioned to capitalize on macroeconomic shifts, evolving demographic preferences and experiential travel demand. Macro resilience meets micro precision Despite persistent headwinds like elevated interest rates and global uncertainty, hospitality investment, particularly in premium segments, continues to exhibit robust performance. Recent data from STR and Tourism Economics forecasts RevPAR (revenue per available room) growth between 3% and 3.7% year-over-year through 2025 for upper-upscale and luxury hotels, surpassing other hotel classes. CoStar's Q1 2025 analysis further confirms the trend, indicating demand growth in luxury hotels exceeding midscale assets by 50-100 basis points. These figures underscore a distinct market bifurcation and highlight why astute investors are targeting premium hospitality. Introducing DLLX: Built for the next generation of travel Recognizing the structural evolution of hospitality, Driftwood recently launched DLLX, a division explicitly designed to harness opportunities in luxury hotels, lifestyle-driven assets and branded residences. Under the leadership of Alinio Azevedo, former CEO of Aspen Hospitality, DLLX targets more than $3 billion in deployments across carefully selected, high-growth domestic and international markets. This strategic initiative aligns with a global surge in high-net-worth and ultra-high-net-worth travelers seeking curated experiences and branded assurance. DLLX's differentiation lies in its integration with Driftwood Hospitality Management (DHM), which currently operates over 80 properties nationwide. This close partnership ensures end-to-end operational excellence from asset acquisition to ongoing management, driving investor returns through operational efficiency and data-driven insights. Case studies: Strategic execution from the Space Coast to Miami Two marquee projects illustrate Driftwood's strategic precision and innovative execution: Westin Cocoa Beach Resort, Spa, and Conference Center: A 502-room beachfront development on Florida's thriving Space Coast. Once complete, Driftwood will control approximately 62% of the beachfront inventory in a region anticipated to benefit from more than 300 annual rocket launches by 2028. Early identification of this market opportunity positions Driftwood for sustained, demand-driven outperformance. Dream Riverside Wharf, Miami: A Hyatt-branded lifestyle property situated on Miami's revitalized riverfront, featuring 165 keys and curated experiential amenities. Positioned in an Opportunity Zone and EB-5 eligible region, this project exemplifies how strategic site selection, demographic appeal and capital structure ingenuity, converge to create multi-dimensional investor benefits. Vertical integration: Driftwood's structural edge Driftwood Capital's unique advantage resides in its comprehensive control over the investment lifecycle — from origination, underwriting, and development to long-term operational management. Leveraging its proprietary Domino technology platform, Driftwood centralizes real-time operational data, enhancing decision-making agility and transparency. This structural integration optimizes cost efficiencies, execution velocity and capital deployment precision, providing investors with institutional-quality access to premium hospitality investments. Investable, experiential, integrated: Hospitality's new paradigm Today's hospitality investment is more than a traditional real estate play. Instead, it's a bet on evolving consumer behaviors and demographic trends. Branded residences, for example, achieve consistent premiums exceeding 30% over non-branded counterparts, reflecting an ongoing shift toward curated lifestyle experiences and brand assurances. With over $5 billion in historical transactions and a robust institutional syndication network, Driftwood Capital and its DLLX division are positioned to lead this new hospitality paradigm. For investors seeking durable yields, capital preservation and strategic upside in an inflation-resilient asset class, DLLX offers more than just thematic appeal. It represents structural alignment with the future of hospitality investment. Learn how Driftwood Capital is turning strategic insight into actionable opportunities by visiting or contacting us directly at . With over $5 billion in transactions to date, Driftwood's platform is built on direct ownership, disciplined underwriting, and operational expertise. Driftwood's business model provides accredited investors (as defined in Rule 501 under Regulation D) access to institutional-quality hotel assets or capital solutions on a direct deal basis following deal closing Learn more at
Business Upturn
an hour ago
- Business Upturn
Arkade Developers shares rise 2% after company announces Rs 2,000 crore Thane project
By Aditya Bhagchandani Published on June 16, 2025, 09:24 IST Shares of Arkade Developers Ltd rose over 2% to ₹195.50 in Monday's early trade after the company announced a strategic land acquisition in Thane. The Mumbai-based real estate company confirmed its foray into the Thane market with a 6.28-acre freehold land parcel at Kasarvadavali, Ghodbunder Road. The company disclosed that the transaction, valued at ₹172.48 crore including stamp duty, is intended for a marquee mixed-use development with a projected gross development value (GDV) of ₹2,000 crore. The project is expected to offer 2, 3, and 4 BHK residences alongside curated retail and commercial spaces, with launch slated for early 2026. The site offers sweeping views of the Sanjay Gandhi National Park and benefits from strong infrastructure connectivity via Eastern Express Highway and the upcoming Metro Line 4 and Thane-Borivali twin tunnel. Arkade Developers Chairman & MD Amit Jain noted that the Thane expansion marks a major milestone in the company's growth, adding to recent developments in Kanjurmarg, Mulund, and Bhandup. The company also highlighted its recent acquisition of the 4-acre Filmistan land parcel in Goregaon with an estimated GDV of ₹3,000 crore. As of the latest update, Arkade Developers shares were trading at ₹195.50, up 2.25% from the previous close of ₹191.20. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
